A Democratic amendment with no cosponsors
Changes S.Con.Res. 7 — An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034.
Offered
Offered, and not voted on yet. Most amendments never get a vote: the Senate takes up the bill and moves on without them.
Its path through Congress
- Introduced
- Pending Consideration
What this amendment would do
This amendment is about setting up a special funding fund for the Food and Drug Administration, specifically to focus on research and product reviews for rare diseases.
What It Aims to Change or Add
The amendment adds a new section to title III of the budget resolution. Here is what it actually does:
- Gives the Chairman of the Senate Committee on the Budget the power to change budget allocations and adjust the pay-as-you-go ledger.
- Targets legislation relating to research and product reviews by the Food and Drug Administration for rare diseases.
- Allows for efforts to speed up the development and approval of treatments.
- Supports improvements in regulatory science.
- Supports research on innovative therapies.
- Requires that any legislation using these funds would not increase the deficit over the total of fiscal years 2025 through 2034.
- 2/20/2025
- Senate amendment submitted
This bill has no cosponsors